Global Eye Allergy Therapeutics Market Report 2019-2023 Featuring Akorn, Allergan, Bausch Health Companies, Novartis, & Santen Pharmaceutical – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Eye Allergy Therapeutics Market 2019-2023” report has been
added to ResearchAndMarkets.com’s offering.

This is expected to propel the growth of the market during the forecast
period. Analysts have predicted that the eye allergy therapeutics market
will register a CAGR of almost 5% by 2023.

The global eye allergy therapeutics market is currently witnessing a
high unmet medical need for a once-daily double-action eye preparation
for the treatment of various types of eye allergies. At present, the
drugs administered for eye allergies are intended to treat symptoms such
as redness and itching, and they provide substantial assistance to
patients leaving approximately 20-30% of the patients untreated.

Also, the side effects associated with the available therapeutic options
limit their use for a long duration. Therefore, the market is currently
exhibiting a need for effective multiple-dose therapies that can treat
the signs and symptoms of eye allergies with a quick onset of action and
without side effects.

Market Overview

Significant comorbidity associated with eye allergies

All types of eye allergies are associated with chronic symptoms such as
ocular itching inflammation redness and watery eyes, which are
persistently disturbing, having an adverse effect on patients’ lives.
This leads to loss of work performance decreased productivity and
increased healthcare costs, which can put a significant economic burden
on patients. To avoid the substantial comorbidity associated with eye
allergies, people spend on the required therapeutics, which will drive
the growth of the market during the forecast period.

Lack of awareness

The level of awareness about eye allergies is generally low. Media and
the Internet were the primary sources of information for most people.
The level of knowledge and awareness regarding eye allergies are low
among medical students and was far lower among those with a non-medical
background. The lack of awareness of the symptoms associated with eye
allergies and the negligence in seeking medical help for their treatment
are expected to limit the growth of the market during the forecast
period.

Competitive Landscape

The market appears to be fragmented. The presence of several companies,
including Akorn Inc. and Allergan Plc, the competitive environment is
quite intense. This market research report will help clients identify
new growth opportunities and design unique growth strategies by
providing a comprehensive analysis of the market’s competitive landscape
and offering information on the products offered by companies. Bausch
Health Companies Inc., Novartis AG, and Santen Pharmaceutical Co. Ltd.
are some of the major companies covered in this report.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

Preface

Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: EYE ALLERGY: AN OVERVIEW

PART 07: PIPELINE ANALYSIS

PART 08: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Antihistamines – Market size and forecast 2018-2023

Mast cell stabilizers – Market size and forecast 2018-2023

Corticosteroids – Market size and forecast 2018-2023

Immunomodulators – Market size and forecast 2018-2023

Others – Market size and forecast 2018-2023

Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 15: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

• Akorn Inc.
• Allergan Plc
• Bausch Health Companies Inc.
• Novartis AG
• Santen Pharmaceutical Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/bymuho

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Allergy
Drugs, Optical
Disorders Drugs